Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2018-09-19
2019-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
2 hours of reduced FiO2 (11-15%) in the inspired air, 2-3x/week, 3 months
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* confirmed MS (all types of MS)
* ability to come to the outpatient clinic 2-3x/week for 3 months
* EDSS ≤ 6.5
* inconspicuous medical examination
* inconspicuous ECG
Exclusion Criteria
* EDSS progression in the last 6 months
* pregnancy
* contraindication for MRI
* severe heart disease
* severe asthma, COPD
* cancer
* severe cognitive deficits
* chronic headache
* renal insufficiency
* anaemia (Hb \< 10 g/dl)
* insulin-dependent diabetes mellitus
* severe vascular stenosis
* former episodes of severe high mountain sickness
* cancer
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Hamburg-Eppendorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. med. Christoph Heesen
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Hamburg-Eppendorf, INIMS
Hamburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS HYPE Pilot
Identifier Type: -
Identifier Source: org_study_id